MAPT and Alzheimer disease: The presence of hyperphosphorylated tau (pTau) in the CSF is linked to NFTs in AD (Schraen‐Maschke et al. 2008), and higher levels of total tau are linked to neurodegeneration (Rawat et al. 2022; Sergeant et al. 2008).